New Products

CAMP HILL, Pa. Rite Aid will introduce Rite Aid Online Care to the Pittsburgh market, a service that offers patients live online interactive personal consultations with specially trained Rite Aid pharmacists via a computer, at the American Diabetes Association on Nov. 6.

EMERYVILLE, Calif. Clif Bar on Thursday announced the introduction of a revamped Clif Shot energy gel, a line of all-natural and organic energy gels with a formula that emphasizes effectiveness, taste and consistency in easy-to-use packaging.

 

NEW YORK KidKupz on Tuesday announced its new medicine-dispensing cups soon will be available nationwide through Walgreens.

 

The KidKupz are fruit-flavored medicine dispensing cups that contain 2 g of sugar and no high-fructose corn syrup.

 

 

SILVER SPRING, Md. The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for allergies, according to FDA records.

 

The drug is a generic version of Schering-Plough’s Clarinex.

 

 

Clarinex has annual sales of around $229 million, according to IMS Health data reported by several media in India, where Lupin is based.

 

PALM BEACH, Fla. Say goodbye to sweat stains with a new pre-treatment stain remover from PharmaWorks.

PitStop, PharmaWorks' new innovation, removes stubborn yellow armpit stains by lifting and dissolving sweat-stain deposits and even can be used on old stains and rings around shirt collars.

PitStop retails for $12.50 for a 12-oz. bottle.

FORT WORTH, Texas Retail pharmacy technology provider PDX has partnered with Healthcare Data Solutions to provide users of the PDX Pharmacy System with access to a real-time prescriber verification process.

The companies said the integration of the PDX Pharmacy System and the HDS ProscriberPRO database would allow immediate verification of prescribers and associated profiles when a prescriber is added or before a prescription is filled, with access provided over a secure, Web-based service.

SILVER SPRING, Md. The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

CHICAGO Three of Lion Brewery's beers now will be available in cans.

Lionshead and Lionshead Light now are available in 12-oz. and 16-oz. aluminum cans, and Stegmaier Gold is on the market in 16-oz. cans, all of which are supplied by Rexam. The beers previously were only offered in glass bottles.